These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30158187)

  • 21. Preparation and in vitro/pharmacokinetic/pharmacodynamic evaluation of a slow-release nano-liposomal form of prednisolone.
    Hosseini SH; Maleki A; Eshraghi HR; Hamidi M
    Drug Deliv; 2016 Oct; 23(8):3008-3016. PubMed ID: 26828453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices.
    Tatavarti AS; Mehta KA; Augsburger LL; Hoag SW
    J Pharm Sci; 2004 Sep; 93(9):2319-31. PubMed ID: 15295792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pollen grains as a novel microcarrier for oral delivery of proteins.
    Lale SV; Gill HS
    Int J Pharm; 2018 Dec; 552(1-2):352-359. PubMed ID: 30308271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of Eudragit L 100-55 enteric nanoparticles by a novel emulsion diffusion method.
    Hao S; Wang B; Wang Y; Zhu L; Wang B; Guo T
    Colloids Surf B Biointerfaces; 2013 Aug; 108():127-33. PubMed ID: 23537830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of new polymer carriers based of Eudragit E PO/Eudragit L100-55 interpolyelectrolyte complexes using swellability measurements.
    Moustafine RI; Bobyleva OV
    J Control Release; 2006 Nov; 116(2):e35-6. PubMed ID: 17718957
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro-in-vivo evaluation.
    Bazan L; Bendas ER; El Gazayerly ON; Badawy SS
    Drug Deliv; 2016 Nov; 23(9):3339-3349. PubMed ID: 27086898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
    Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
    Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
    Huang J; Wigent RJ; Schwartz JB
    Drug Dev Ind Pharm; 2006; 32(10):1185-97. PubMed ID: 17090441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of prolonged release clarithromycin microparticles for oral use and their in vitro evaluation.
    Genç L; Demirel M; Yazan Y
    Arch Pharm Res; 2006 Oct; 29(10):921-7. PubMed ID: 17121189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
    Shastri PN; Ubale RV; D'Souza MJ
    Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of burst release from pH-responsive polymeric microparticles.
    Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
    J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles.
    Dong WY; Maincent P; Bodmeier R
    Int J Pharm; 2007 Feb; 331(1):84-92. PubMed ID: 17081708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO.
    Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY
    Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres.
    Onishi H; Oosegi T; Machida Y; McGinity JW
    Drug Dev Ind Pharm; 2007 Aug; 33(8):848-54. PubMed ID: 17729102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.
    Kislalioglu MS; Khan MA; Blount C; Goettsch RW; Bolton S
    J Pharm Sci; 1991 Aug; 80(8):799-804. PubMed ID: 1791544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buccal films of prednisolone with enhanced bioavailability.
    Kumria R; Nair AB; Goomber G; Gupta S
    Drug Deliv; 2016; 23(2):471-8. PubMed ID: 24892626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.